ZVSA

ZyVersa Therapeutics
ZVSA

Delisted

ZVSA was delisted on the 16th of July, 2025.

Back to rankings

7 hedge funds and large institutions have $43.9K invested in ZyVersa Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.2K
2
+$13.6K
3
+$1

Top Sellers

1
-$37.1K
2
-$13.7K
3
-$4.85K
4
TRCT
Tower Research Capital (TRC)
New York
-$835
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$17.8K
Geode Capital Management
2
Geode Capital Management
Massachusetts
$13.6K
VF
3
Virtu Financial
New York
$11K
TRCT
4
Tower Research Capital (TRC)
New York
$1.35K
Bank of America
5
Bank of America
North Carolina
$70
SS
6
SBI Securities
Japan
$31
Morgan Stanley
7
Morgan Stanley
New York
$1
Citigroup
8
Citigroup
New York
–
Renaissance Technologies
9
Renaissance Technologies
New York
–